Head of Regulatory Affairs, PTD BU
Sascha Haverfield is the Head, Regulatory Affairs for Takeda’s Plasma-derived Therapies Business Unit. He also serves as the Global Program Lead for Takeda’s Hyperimmune Globulin Platform team, including the development of an anti-SARS-CoV-2 Hyperimmune Globulin (CoVIg-19) therapy.
Located in Cambridge, MA, Sascha Haverfield previously served as the Group Vice President and Head of EU and International Regulatory Affairs at Shire, where he led a group of over 200 regulatory affairs professionals across the European Union, Canada, LATAM, EAMEA, APAC and Japan. Prior to that he was the Vice President for Global Regulatory Strategy and Therapeutic Area Head for CNS, Ophthalmology and Oncology at Shire.
Sascha has over 18 years of biopharmaceutical and trade association experience, combining a strong scientific background with in-depth regulatory, drug development and health policy expertise. Prior to joining Shire, Sascha Haverfield was the Senior Vice President, Science and Regulatory Advocacy at the Pharmaceutical Research and Manufacturers of America (PhRMA). He is recognized as the architect of the biopharmaceutical industry’s Continuous Engagement Strategy and was responsible for the implementation and reauthorization of the Prescription Drug User Fee Act and the Biosimilar User Fee Act. During his time in Washington, DC he served as the staff lead for PhRMA’s Regulatory Affairs Coordinating Committee resulting in the development and implementation of pro-innovation biopharmaceutical industry positions and policies.
Sascha Haverfield began his industry career in the drug discovery division of deCODE genetics in Reykjavik, Iceland. Prior to joining PhRMA, Sascha covered global regulatory affairs issues for Abbott Laboratories with a focus on the USA, European Union, Japan, and the emerging markets of Russia, India and China. Dr. Haverfield completed his undergraduate studies in Biological Sciences at the University of Marburg, Germany. He received a Doctorate in Genetics and Cell Biology from the University of Oxford, Oriel College, UK.
Tuesday, September 15, 2020
11:00 AM – 12:30 PM EDT